Squarepoint Ops LLC Makes New Investment in Inhibikase Therapeutics, Inc. (NYSE:IKT)
Squarepoint Ops LLC acquired a new stake in Inhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 28,411 shares of the company’s stock, valued at approximately $92,000. Several other institutional investors and hedge […]
Squarepoint Ops LLC acquired a new stake in Inhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 28,411 shares of the company’s stock, valued at approximately $92,000. Several other institutional investors and hedge […]
